Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced it will present a corporate overview at the Leerink Partners Rare Disease Roundtable on Wednesday, October 1, 2014 at 10:15 a.m. EDT at Le Parker Meridien Hotel in New York City.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
